Table 1:
Recipient Characteristics by Transplant Type (Non-dialysis-dependent Only)
| HA Non-dialysis-dependent | SHK Non-dialysis-dependent | p-value | |
|---|---|---|---|
| N=28,887 | N=601 | ||
| Gender(Female)-n(%) | 7,329 (25%) | 123 (20%) | 0.006 |
| Age-Med (IQR) | 55.0 (46.0–62.0) | 58.0 (51.0–64.0) | <0.001 |
| Race-n(%) | <0.001 | ||
| Asian | 879 ( 3%) | 17 ( 3%) | |
| Black | 5,647 (20%) | 165 (27%) | |
| Multiethnic | 122 ( 0%) | 2 ( 0%) | |
| Native American | 93 ( 0%) | 1 ( 0%) | |
| Pacific Islander | 94 ( 0%) | 3 ( 0%) | |
| White | 22,052 (76%) | 413 (69%) | |
| Insurance Status-n(%) | 0.76 | ||
| Public | 13,783 (48%) | 292 (49%) | |
| Private | 14,840 (51%) | 305 (51%) | |
| Self | 264 ( 1%) | 4 ( 1%) | |
| HTx Center Volume-Med(IQR) | 22.6 (15.6–41.9) | 25.3 (16.1–41.9) | 0.072 |
| SHK Center Volume-Med(IQR) | 0.9 (0.3–1.5) | 1.4 (0.9–2.4) | <0.001 |
| eGFR (CKD EPI, mL/min/1.73m2) -Med(IQR) | 68 (51–89) * | 29 (23–39)* | <0.001 |
| Serum Albumin(g/dL) -Med(IQR) | 3.8 (3.3–4.2)† | 3.7 (3.2–4.1) & | 0.030 |
| Primary Cause of Heart Failure-n(%) | 0.27 | ||
| Autoimmune | 456 ( 2%)* | 14 ( 2%)* | |
| Congenital | 1,769 ( 6%) | 29 ( 5%) | |
| Idiopathic | 11,618 (40%) | 231 (39%) | |
| Infectious | 618 ( 2%) | 13 ( 2%) | |
| Ischemic | 11,309 (39%) | 241 (41%) | |
| Other | 2,575 ( 9%) | 48 ( 8%) | |
| Valvular | 507 ( 2%) | 16 ( 3%) | |
| Last Status Before Transplant-n(%) | 0.166 | ||
| Status 1A | 15,383(53%)* | 337(56) | |
| Status 1B | 10,471(36%) | 214(36) | |
| Status 2 | 3,029(11%) | 50(8) | |
| Diabetes-n(%) | 7,509 (26%)* | 240 (40%)* | <0.001 |
| Hypertension-n(%) | 10,596 (50%)† | 291 (76%)† | <0.001 |
| Body Mass Index (BMI)-Med(IQR) | 26.8 (23.6–30.4)* | 26.4 (23.2–29.9)* | 0.038 |
| Cardiac Index (L/min/m^2)-Med(IQR) | 2.2 (1.8–2.7)^ | 2.4 (2.0–2.9)& | <0.001 |
| Systolic PAP (mmHg)-Med(IQR) | 39 (30–50)^ | 42 (33–52)^ | <0.001 |
| Mean PAP (mmHg)-Med(IQR) | 27 (20–34)^ | 28 (22–36)^ | <0.001 |
| PCWP (mmHg)-Med(IQR) | 18 (12–24)& | 19 (14–25)& | <0.001 |
| Any Life Support (Mechanical Support or Inotropes) -n(%) | 22,128 (77%) | 452 (75%) | 0.42 |
| Ventricular Assist Device (VAD)-n(%) | 11,323 (39%)* | 167 (28%) | <0.001 |
| Inotropes-n(%) | 11,402 (39%) | 285 (47%) | <0.001 |
| Ventilator-n(%) | 486 ( 2%) | 5 ( 1%) | 0.11 |
| IABP-n(%) | 1,684 ( 6%) | 40 ( 7%) | 0.39 |
| ECMO-n(%) | 176 ( 1%) | 1 ( 0%) | 0.16 |
*
0–5% Missing
^
5–10% Missing
&
10–20% Missing
†
>20% Missing